Huntington National Bank lifted its stake in shares of CME Group Inc (NASDAQ:CME) by 31.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,189 shares of the financial services provider’s stock after purchasing an additional 530 shares during the quarter. Huntington National Bank’s holdings in CME Group were worth $373,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently made changes to their positions in CME. Meeder Asset Management Inc. increased its position in CME Group by 84.8% in the 2nd quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock valued at $129,000 after acquiring an additional 362 shares during the period. Kaizen Advisory LLC increased its position in CME Group by 151.9% in the 2nd quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock valued at $134,000 after acquiring an additional 492 shares during the period. Sun Life Financial INC increased its position in CME Group by 267.7% in the 2nd quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock valued at $151,000 after acquiring an additional 672 shares during the period. Cornerstone Wealth Management LLC acquired a new stake in CME Group in the 2nd quarter valued at approximately $153,000. Finally, HMS Capital Management LLC acquired a new stake in CME Group in the 2nd quarter valued at approximately $207,000. Institutional investors and hedge funds own 84.30% of the company’s stock.
Several brokerages have recently issued reports on CME. Berenberg Bank set a $184.00 price target on CME Group and gave the company a “hold” rating in a research report on Thursday, September 20th. Wells Fargo & Co lifted their price target on CME Group from $170.00 to $175.00 and gave the company a “market perform” rating in a research report on Monday, July 9th. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Compass Point began coverage on CME Group in a research report on Monday, July 9th. They set a “neutral” rating and a $170.00 price target on the stock. Finally, Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Five equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. CME Group currently has a consensus rating of “Buy” and a consensus price target of $181.38.
Shares of CME stock opened at $181.22 on Tuesday. The firm has a market cap of $62.01 billion, a PE ratio of 30.91, a PEG ratio of 3.47 and a beta of 0.64. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.08 and a current ratio of 1.08. CME Group Inc has a 1 year low of $132.33 and a 1 year high of $183.79.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, July 26th. The financial services provider reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.02. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The company’s revenue was up 14.6% compared to the same quarter last year. During the same period last year, the company posted $1.22 EPS. As a group, research analysts expect that CME Group Inc will post 6.57 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 25th. Stockholders of record on Monday, September 10th were paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.55%. The ex-dividend date was Friday, September 7th. CME Group’s dividend payout ratio is presently 58.70%.
In other news, President Bryan T. Durkin sold 11,509 shares of the firm’s stock in a transaction on Monday, August 6th. The stock was sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the completion of the sale, the president now directly owns 64,862 shares of the company’s stock, valued at approximately $10,508,292.62. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Ronald A. Pankau sold 260 shares of the firm’s stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the sale, the director now directly owns 3,900 shares of the company’s stock, valued at $636,363. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,188 shares of company stock valued at $4,973,607. Corporate insiders own 0.43% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Story: What are CEFs?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.